Agents Used in Antiretroviral Therapy

  • Authors: Philip Grant, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 4/9/19 (What's New)

Summary

  • Etravirine is indicated in combination with other antiretroviral agents for treatment of HIV infection in treatment-experienced adult patients who have evidence of viral replication and resistance to an NNRTI and other antiretroviral agents[FDA Etravirine]
    • Major advantage of etravirine compared with first-generation NNRTIs is its activity against many NNRTI-resistant variants
    • K103N mutation alone has not been shown to compromise activity of etravirine

Action required

Keywords: Dermatologic Complications, Initial Antiretroviral Therapy, Pregnancy, Special Populations, Treatment Complications

©2018 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.